Explore comprehensive CDMO services offered by STC Biologics, supporting end-to-end Anlaytical Testing, Clinical Studies, Drug Development and Manufacturing. STC Biologics enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A.
Description: STC Biologics is a boutique contract development and manufacturing organization (CDMO) founded in 2009, located in Newton, Massachusetts, that specializes in the development of biologic drugs, particularly biosimilars. The company offers full Chemistry, Manufacturing, and Controls (CMC) services to help partners advance their products from discovery to commercial approval. Key aspects of its business include analytics-driven process development, cell line development, and a focus on monoclonal antibodies, with expertise in areas like oncology and immune diseases.